PharmaEssentia U.S.A is a rapidly growing biopharmaceutical innovator dedicated to transforming the lives of patients with challenging diseases, particularly in the fields of hematology and oncology. Founded in 2003 by a team of Taiwanese-American executives and renowned scientists, the company leverages deep expertise and proven scientific principles to develop effective new biologics. With one product already approved and a diversifying pipeline, PharmaEssentia is committed to improving health and quality of life for patients with limited options. The company is publicly listed on the Taiwan Stock Exchange and has expanded its global presence with operations in the U.S., Japan, Singapore, South Korea, and China, including a state-of-the-art biologics production facility in Taichung. PharmaEssentia values diversity and inclusion, striving to create an environment of mutual respect and equal opportunity for all employees.